RESUMEN
The Beijing oil (BJO) chicken is an autochthona Chinese breed which shows outstanding meat quality characteristics compared with fast-growing imported chickens such as Arbor Acres (AA) chickens. Gut microbial diversity has been shown to influence host factors such as energy and nutrient metabolism, immune response and fertility. Consequently, it is hoped that analyses into host microbial populations will ultimately help to improve the quality of associated meat products. Two distinct chicken breeds, Arbor Acres (AA) and Beijing oil (BJO), were selected to analyze the composition of the 16S rRNA gene V3-V5 hypervariable regions using high-throughput sequencing technology. Upon elucidation of gut-colonizing bacteria, the Firmicutes were observed to encompass the dominant phylum. The abundance of Firmicutes in the BJO chickens (84.9%) was lower than in the AA chickens (89.9%). Conversely, the prevalence of Proteobacteria was 4.8% in BJO chickens, with a significantly lower abundance observed in AA chickens (1.3%). In the cecum, the Firmicutes were once more the dominant phylum in BJO chickens (60.2%) and AA chickens (63.7%). The abundance of bacteroidetes was 37.7% in BJO chickens and 34.9% in AA chickens, respectively. These discoveries provide a perception into the composition of the gut microbiotain both breeds. The study also provides a foundation for future research relating to gut bacterial factors that may influence the development and progression of gastrointestinal disease in chickens and other animals.
Asunto(s)
Animales , Pollos/crecimiento & desarrollo , Pollos/microbiología , Interacciones MicrobianasRESUMEN
The Beijing oil (BJO) chicken is an autochthona Chinese breed which shows outstanding meat quality characteristics compared with fast-growing imported chickens such as Arbor Acres (AA) chickens. Gut microbial diversity has been shown to influence host factors such as energy and nutrient metabolism, immune response and fertility. Consequently, it is hoped that analyses into host microbial populations will ultimately help to improve the quality of associated meat products. Two distinct chicken breeds, Arbor Acres (AA) and Beijing oil (BJO), were selected to analyze the composition of the 16S rRNA gene V3-V5 hypervariable regions using high-throughput sequencing technology. Upon elucidation of gut-colonizing bacteria, the Firmicutes were observed to encompass the dominant phylum. The abundance of Firmicutes in the BJO chickens (84.9%) was lower than in the AA chickens (89.9%). Conversely, the prevalence of Proteobacteria was 4.8% in BJO chickens, with a significantly lower abundance observed in AA chickens (1.3%). In the cecum, the Firmicutes were once more the dominant phylum in BJO chickens (60.2%) and AA chickens (63.7%). The abundance of bacteroidetes was 37.7% in BJO chickens and 34.9% in AA chickens, respectively. These discoveries provide a perception into the composition of the gut microbiotain both breeds. The study also provides a foundation for future research relating to gut bacterial factors that may influence the development and progression of gastrointestinal disease in chickens and other animals.(AU)
Asunto(s)
Animales , Interacciones Microbianas , Pollos/crecimiento & desarrollo , Pollos/microbiologíaRESUMEN
Psoriasis is a common chronic relapsing inflammatory skin disease, in which mesenchymal stem cells (MSCs) have been hypothesized to play an important role in abnormal localized inflammation and vascular proliferation observed in skin lesions. Previous studies have revealed abnormal gene expression patterns, DNA methylation status, and cytokine secretion of MSCs in psoriatic skin lesions, as well as some gene expression abnormalities related to inflammation and angiogenesis. We further verified the gene and protein expressions of inflammation-related lipopolysaccharide-induced tumor necrosis factor-alpha transcription factor (LITAF), dual-specificity protein phosphatase 1 (DUSP1), and angiogenesis-related hematopoietically expressed homeobox (HHEX) in MSCs derived from the skin lesions of psoriasis patients. The gene expression of LITAF, DUSP1, and HHEX in dermal MSCs was measured at the mRNA level using reverse transcription-polymerase chain reaction and the corresponding protein expression levels were analyzed by western blotting analysis. The gene and protein expression levels of LITAF, HHEX, and DUSP1 in dermal MSCs were significantly lower in psoriasis patients compared to controls. Amplification and western blotting results were consistent with our previously reported gene chip data. Our results suggest that dermal MSCs in psoriatic skin lesions may be involved in the development, progression, and regulation of localized inflammatory abnormalities by reducing the expression of LITAF, HHEX, and DUSP1, which are related to inflammation and angiogenesis.
Asunto(s)
Fosfatasa 1 de Especificidad Dual/genética , Expresión Génica , Proteínas de Homeodominio/genética , Células Madre Mesenquimatosas/metabolismo , Proteínas Nucleares/genética , Psoriasis/genética , Factores de Transcripción/genética , Adulto , Estudios de Casos y Controles , Fosfatasa 1 de Especificidad Dual/metabolismo , Femenino , Proteínas de Homeodominio/metabolismo , Humanos , Masculino , Persona de Mediana Edad , Proteínas Nucleares/metabolismo , Psoriasis/diagnóstico , ARN Mensajero/genética , ARN Mensajero/metabolismo , Índice de Severidad de la Enfermedad , Factores de Transcripción/metabolismo , Adulto JovenRESUMEN
The A1298C polymorphism of the methylenetetrahydrofolate reductase (MTHFR) gene has been reported to be associated with hepatocellular carcinoma (HCC), but there are conflicting results from previous studies. The present study aimed to investigate the association between this polymorphism and the risk of HCC using a meta-analysis of the published studies. Published literature from PubMed and Embase databases was systematically searched to identify relevant studies before October 2014. The Begg test was used to measure publication bias. Sensitivity analyses were performed to ensure the authenticity of the outcome. The meta-analysis results showed significant association between the MTHFR A1298C polymorphism and HCC risk (CC vs AA: OR = 0.52, 95%CI = 0.33-0.81; CC vs AC: OR = 0.50, 95%CI = 0.32-0.79; dominant model: OR = 1.94, 95%CI = 1.24-3.02; recessive model: OR = 1.00, 95%CI = 0.84-1.18). In the subgroup analysis, significant associations between the MTHFR A1298C polymorphism and HCC risk were found in Asians (CC vs AA: OR = 0.46, 95%CI = 0.27-0.78; CC vs AC: OR = 0.41, 95%CI = 0.24-0.71; dominant model: OR = 2.27, 95%CI = 1.33-3.86; recessive model: OR = 1.03, 95%CI = 0.86-1.24). Our results suggest that the MTHFR A1298C polymorphism might be related to increased risk of HCC in Asians. Further large and well-designed studies are needed to confirm these conclusions.
Asunto(s)
Alelos , Carcinoma Hepatocelular/genética , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Neoplasias Hepáticas/genética , Metilenotetrahidrofolato Reductasa (NADPH2)/genética , Polimorfismo de Nucleótido Simple , Carcinoma Hepatocelular/epidemiología , Estudios de Casos y Controles , Humanos , Neoplasias Hepáticas/epidemiología , Oportunidad Relativa , Sesgo de Publicación , RiesgoRESUMEN
We developed a forced non-electric-shock running wheel (FNESRW) system that provides rats with high-intensity exercise training using automatic exercise training patterns that are controlled by a microcontroller. The proposed system successfully makes a breakthrough in the traditional motorized running wheel to allow rats to perform high-intensity training and to enable comparisons with the treadmill at the same exercise intensity without any electric shock. A polyvinyl chloride runway with a rough rubber surface was coated on the periphery of the wheel so as to permit automatic acceleration training, and which allowed the rats to run consistently at high speeds (30 m/min for 1 h). An animal ischemic stroke model was used to validate the proposed system. FNESRW, treadmill, control, and sham groups were studied. The FNESRW and treadmill groups underwent 3 weeks of endurance running training. After 3 weeks, the experiments of middle cerebral artery occlusion, the modified neurological severity score (mNSS), an inclined plane test, and triphenyltetrazolium chloride were performed to evaluate the effectiveness of the proposed platform. The proposed platform showed that enhancement of motor function, mNSS, and infarct volumes was significantly stronger in the FNESRW group than the control group (P<0.05) and similar to the treadmill group. The experimental data demonstrated that the proposed platform can be applied to test the benefit of exercise-preconditioning-induced neuroprotection using the animal stroke model. Additional advantages of the FNESRW system include stand-alone capability, independence of subjective human adjustment, and ease of use.
Asunto(s)
Animales , Masculino , Prueba de Esfuerzo/métodos , Terapia por Ejercicio/métodos , Infarto de la Arteria Cerebral Media/prevención & control , Esfuerzo Físico , Condicionamiento Físico Animal/instrumentación , Calibración , Infarto Cerebral/patología , Infarto Cerebral/prevención & control , Modelos Animales de Enfermedad , Diseño de Equipo , Invenciones , Infarto de la Arteria Cerebral Media/patología , Resistencia Física , Distribución Aleatoria , Ratas Wistar , Índice de Severidad de la Enfermedad , Programas Informáticos , Factores de TiempoRESUMEN
We developed a forced non-electric-shock running wheel (FNESRW) system that provides rats with high-intensity exercise training using automatic exercise training patterns that are controlled by a microcontroller. The proposed system successfully makes a breakthrough in the traditional motorized running wheel to allow rats to perform high-intensity training and to enable comparisons with the treadmill at the same exercise intensity without any electric shock. A polyvinyl chloride runway with a rough rubber surface was coated on the periphery of the wheel so as to permit automatic acceleration training, and which allowed the rats to run consistently at high speeds (30 m/min for 1 h). An animal ischemic stroke model was used to validate the proposed system. FNESRW, treadmill, control, and sham groups were studied. The FNESRW and treadmill groups underwent 3 weeks of endurance running training. After 3 weeks, the experiments of middle cerebral artery occlusion, the modified neurological severity score (mNSS), an inclined plane test, and triphenyltetrazolium chloride were performed to evaluate the effectiveness of the proposed platform. The proposed platform showed that enhancement of motor function, mNSS, and infarct volumes was significantly stronger in the FNESRW group than the control group (P<0.05) and similar to the treadmill group. The experimental data demonstrated that the proposed platform can be applied to test the benefit of exercise-preconditioning-induced neuroprotection using the animal stroke model. Additional advantages of the FNESRW system include stand-alone capability, independence of subjective human adjustment, and ease of use.
Asunto(s)
Prueba de Esfuerzo/métodos , Terapia por Ejercicio/métodos , Infarto de la Arteria Cerebral Media/prevención & control , Condicionamiento Físico Animal/instrumentación , Esfuerzo Físico , Animales , Calibración , Infarto Cerebral/patología , Infarto Cerebral/prevención & control , Modelos Animales de Enfermedad , Diseño de Equipo , Infarto de la Arteria Cerebral Media/patología , Invenciones , Masculino , Resistencia Física , Distribución Aleatoria , Ratas Wistar , Índice de Severidad de la Enfermedad , Programas Informáticos , Factores de TiempoRESUMEN
Accumulating evidence has indicated the importance of cancer stem cells in carcinogenesis. The goal of the present study was to determine the effect of low-dose cisplatin on enriched liver cancer stem cells (LCSCs). Human hepatoblastoma HepG2 cells were treated with concentrations of cisplatin ranging from 1 to 5 μg/mL. Cell survival and proliferation were evaluated using a tetrazolium dye (MTT) assay. LCSCs were identified using specific markers, namely aldehyde dehydrogenase-1 (ALDH1) and CD133. The percentage of ALDH1+ or CD133+ cells was examined by flow cytometric analysis. The expression of ALDH1 and/or CD133 in HepG2 cells was determined by immunocytochemical analysis. Low-dose cisplatin treatment significantly decreased cell survival in HepG2 cells after 24 or 72 h. However, the percentage of LCSCs in the surviving cells was greatly increased. The percentage of ALDH1+ or CD133+ cells was increased in a time- and dose-dependent manner after treatment with 1-4 μg/mL cisplatin, whereas 5 μg/mL cisplatin exposure slightly reduced the number of positive cells. These findings indicate that low-dose cisplatin treatment may efficiently enrich the LCSC population in HepG2 cells.
Asunto(s)
Humanos , Antineoplásicos/administración & dosificación , Proliferación Celular/efectos de los fármacos , Cisplatino/administración & dosificación , Hepatoblastoma/tratamiento farmacológico , Neoplasias Hepáticas/tratamiento farmacológico , Células Madre Neoplásicas/efectos de los fármacos , Antígenos CD/análisis , Línea Celular Tumoral , Carcinogénesis/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Cisplatino/uso terapéutico , Citometría de Flujo , Glicoproteínas/análisis , Hepatoblastoma/patología , Inmunohistoquímica , Isoenzimas/análisis , Neoplasias Hepáticas/patología , Células Madre Neoplásicas/citología , Péptidos/análisis , Retinal-Deshidrogenasa/análisis , Sales de Tetrazolio , Biomarcadores de Tumor/análisisRESUMEN
Accumulating evidence has indicated the importance of cancer stem cells in carcinogenesis. The goal of the present study was to determine the effect of low-dose cisplatin on enriched liver cancer stem cells (LCSCs). Human hepatoblastoma HepG2 cells were treated with concentrations of cisplatin ranging from 1 to 5 µg/mL. Cell survival and proliferation were evaluated using a tetrazolium dye (MTT) assay. LCSCs were identified using specific markers, namely aldehyde dehydrogenase-1 (ALDH1) and CD133. The percentage of ALDH1+ or CD133+ cells was examined by flow cytometric analysis. The expression of ALDH1 and/or CD133 in HepG2 cells was determined by immunocytochemical analysis. Low-dose cisplatin treatment significantly decreased cell survival in HepG2 cells after 24 or 72 h. However, the percentage of LCSCs in the surviving cells was greatly increased. The percentage of ALDH1+ or CD133+ cells was increased in a time- and dose-dependent manner after treatment with 1-4 µg/mL cisplatin, whereas 5 µg/mL cisplatin exposure slightly reduced the number of positive cells. These findings indicate that low-dose cisplatin treatment may efficiently enrich the LCSC population in HepG2 cells.
Asunto(s)
Antineoplásicos/administración & dosificación , Proliferación Celular/efectos de los fármacos , Cisplatino/administración & dosificación , Hepatoblastoma/tratamiento farmacológico , Neoplasias Hepáticas/tratamiento farmacológico , Células Madre Neoplásicas/efectos de los fármacos , Antígeno AC133 , Familia de Aldehído Deshidrogenasa 1 , Antígenos CD/análisis , Biomarcadores de Tumor/análisis , Carcinogénesis/efectos de los fármacos , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Cisplatino/uso terapéutico , Citometría de Flujo , Glicoproteínas/análisis , Células Hep G2 , Hepatoblastoma/patología , Humanos , Inmunohistoquímica , Isoenzimas/análisis , Neoplasias Hepáticas/patología , Células Madre Neoplásicas/citología , Péptidos/análisis , Retinal-Deshidrogenasa/análisis , Sales de TetrazolioRESUMEN
Gilbert's syndrome is suspected in patients with unconjugated hyperbilirubinemia caused by decreased activity of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene in the absence of abnormal liver function and hemolysis. The major genetic variants underlying Gilbert's syndrome are TATA-box repeats of the promoter region and exon 1 G211A of the coding region, particularly in Asians. The efficacy of DNA melting curve analysis, however, has not been established for the G211A mutation. For rapid and accurate molecular diagnosis of Gilbert's syndrome, DNA melting curve analysis was evaluated for its genotyping capability not only for TATA-box repeats of the UGT1A1 promoter, but also for G211A of UGT1A1 exon 1. TA repeats within the TATA-box sequence and the exon 1 G211A mutation of the UGT1A1 gene were analyzed by DNA melting curve analysis. To evaluate the assay reliability, direct sequencing or polyacrylamide gel electrophoresis was used as a comparative method. All homozygous and heterozygous polymorphisms of A(TA)7TAA within the TATA-box allele and of exon 1 G211A mutants of the UGT1A1 gene were successfully identified with DNA melting curve analysis. DNA melting curve analysis is, therefore, an effective molecular method for the rapid diagnosis of Gilbert's syndrome, as it detects not only TATA-box polymorphisms but also the exon 1 G211A mutation located within the UGT1A1 gene.
Asunto(s)
Enfermedad de Gilbert/genética , Glucuronosiltransferasa/genética , Patología Molecular , Alelos , Pueblo Asiatico/genética , Exones , Genotipo , Enfermedad de Gilbert/diagnóstico , Humanos , Mutación , Desnaturalización de Ácido Nucleico/genética , Polimorfismo Genético , Regiones Promotoras Genéticas , TATA Box/genéticaRESUMEN
Outbreaks of influenza due to the virus A/Hong Kong/1/68 (H3N2) began in 1968 and are still occurring. The haemagglutinin of this virus is different from that of the A/Singapore/1/57 virus (the "Asian" strain) but the neuraminidase antigens are the same. Between 1968 and 1971 only minor antigenic "drift" in the haemagglutinin was noted, but in recent months 2 isolates have been identified in which considerable "drift" has occurred in the haemagglutinin and in the neuraminidase antigens. One, A/Hong Kong/5/72 (H3N2), was first detected in outbreaks in Hong Kong between November 1971 and January 1972 and was predominant there and in Korea but did not become widely disseminated. The second strain, A/England/42/72 (H3N2), has been isolated in winter outbreaks in the southern hemisphere and now appears to be the predominant strain in the northern hemisphere. The characteristics of the strains are described.
Asunto(s)
Antígenos Virales , Genética Microbiana , Inmunogenética , Orthomyxoviridae/inmunología , África , Asia , Australia , Europa (Continente) , Pruebas de Inhibición de Hemaglutinación , Humanos , Inmunodifusión , Gripe Humana/epidemiología , Neuraminidasa/antagonistas & inhibidores , América del Norte , América del SurRESUMEN
This paper is a report on the first (serological) phase of a study organized by WHO in collaboration with the WHO International Reference Centre for Respiratory Virus Diseases other than Influenza in Bethesda, Md., USA, to define the viral etiology of severe respiratory infections in children, particularly in tropical areas. Paired sera from 528 children up to 5 years old admitted to hospital with severe respiratory illness of probable viral etiology were collected in 10 countries and sent frozen to the International Reference Centre, where standard complement-fixation tests were made for the following agents: parainfluenza virus types 1, 2 and 3, influenza virus types A and B, adenoviruses, respiratory syncytial virus, Mycoplasma pneumoniae, Coxiella burneti and psittacosis-ornithosis.Some 41% of paired sera showed rising antibody titres for one or more of these agents, multiple infections being observed in 8%. In most of the countries the pattern of infection was similar. RS virus was the most important respiratory tract pathogen of early life, particularly in the first year of life and in cases of bronchiolitis and pneumonia; the parainfluenza viruses were next in importance, particularly in cases of croup, but, in contra-distinction to RS virus infections, they were commoner in older children. Influenza, adenoviruses, and M. pneumoniae were of moderate importance, and C. burneti and the psittacosis-ornithosis agents were relatively rare. This pattern is similar to that which has been observed in temperate climates.
Asunto(s)
Infecciones del Sistema Respiratorio/etiología , Virosis/complicaciones , África , Factores de Edad , Asia , Preescolar , Pruebas de Fijación del Complemento , Encuestas Epidemiológicas , Humanos , India , Lactante , Infecciones del Sistema Respiratorio/inmunología , América del Sur , Virosis/inmunologíaRESUMEN
This paper is a report on the first (serologicl) phase of a study organized by WHO in collaboration with the WHO International Reference Centre for Respiratory Virus Diseases other than Influenza in Bethesda, Md., USA, to define the viral etiology of severe respiratory infections in children, particularly in tropical areas. Paired sera from 528 children up to 5 years old admitted to hospital with severe respiratory illness of probable viral etiology were collected in 10 countries and sent frozen to the International Reference Centre, where standard complement-fixation tests were made for the following agents: parainfluenza virus types 1, 2 and 3, influenza virus types A and B, adenoviruses, respiratoy syncytial virus, Mycoplasma pneumoniae, Coxiella burneti and psittacosis-ornithosis. Some 41 percent of paired sera showed rising antibody titres for one or more of these agents, multiple infections being observed in 8 percent. In most of the countries the pattern of life, particularly in the first year of life and in cases of bronchiolitis and pneumonia; the distinction to RS virus infections, they were commoner in older children. Influenza, adenoviruses, and M. pneumoniae were of moderate importance, and C. burneti and the psittacosis-ornithosis agents were relatively rare. This pattern is similar to that which has been observed in temperate climates (AU)